NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Caffeine Consumption Aboard the International Space StationINTRODUCTION: Caffeine is the most widely used performance-enhancing drug on Earth and astronaut crews have access to liquid coffee. While caffeine is a potent countermeasure to improve alertness and performance, it can also interfere with sleep. This can lead to performance deficits on the following day, driving a cycle of caffeine use to counter the effects of caffeine-induced sleep disruption. Caffeine availability may be limited during future Artemis and/or Mars missions. Accordingly, it is important that we 1) determine the prevalence of caffeine use among astronauts, 2) characterize the impact of caffeine on performance, and 3) characterize the impact of caffeine on sleep. Our aim in this study is to describe the use of caffeine aboard the ISS and begin to examine the relationship between caffeine use and sleep and performance outcomes.

METHODS: Daily caffeine consumption was determined from food and beverage intake tracking for 25 astronauts on 6 month International Space Station (ISS) missions. Data were recorded using the ISS Food Intake Tracker iPad App or other detailed recording technique. On average, crew recorded dietary intake on 179.7±68.6 (mean±SD) days inflight.

RESULTS: Astronauts consumed 97±92 mg caffeine per day. All astronauts (25/25) in this study consumed caffeine at some point during flight, though the frequency, amounts, and regularity differed across crewmembers. Approximately a quarter of crewmembers were regular caffeine consumers (6/25), i.e., they ingested at least 90 mg caffeine (equivalent to one cup of coffee) on 90% of inflight days.
Document ID
20240004245
Acquisition Source
Ames Research Center
Document Type
Presentation
Authors
Rachel A Jansen
(Ames Research Center Mountain View, United States)
Alisa M Braun
(San Jose State University San Jose, United States)
Zachary L Glaros
(Ames Research Center Mountain View, United States)
Sara R Zwart
(Wyle (United States) El Segundo, California, United States)
Scott M Smith
(Johnson Space Center Houston, United States)
Erin E Flynn-Evans
(Ames Research Center Mountain View, United States)
Date Acquired
April 9, 2024
Subject Category
Space Sciences (General)
Meeting Information
Meeting: 94th Aerospace Medical Association (AsMA) Annual Scientific Meeting
Location: Chicago, IL
Country: US
Start Date: May 5, 2024
End Date: May 9, 2024
Sponsors: Aerospace Medical Association
Funding Number(s)
CONTRACT_GRANT: NNX17AE07A
Distribution Limits
Public
Copyright
Public Use Permitted.
Technical Review
NASA Peer Committee
Keywords
fatigue
sleep
space
No Preview Available